Research


September 9, 2021

UAMS Research Team Finds Potential Cause of COVID-19 ‘Long-haulers’

David Robinson

Terry Harville, M.D., Ph.D., consults with John Arthur, M.D., Ph.D., in the UAMS Pathology Lab.

LITTLE ROCK — A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is an antibody that shows up weeks after an…


August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).


August 23, 2021

UAMS Researchers Awarded $2.5 Million Grant to Create Phone App to Prevent Opioid Use Relapse

Yavonda Chase

Andrew James, Ph.D., a neuroimaging scientist in UAMS’ Brain Imaging Research Center, seeks to understand how the reward systems of the brain change during recovery from opioid use disorder.

LITTLE ROCK — A team of UAMS research scientists has been awarded a five-year grant worth $2.5 million from the National Institute on Drug Abuse to determine if a cell phone application can reduce the relapse rate in people with opioid use disorder.


August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.


July 28, 2021

UAMS Research Looks at Arkansans’ Preferred COVID-19 Testing Sites, Reasons for Not Getting Tested

David Wise

Ronald Brimberry, M.D., administers a COVID-19 test at a drive-thru testing site at the UAMS Northwest Regional Campus in Fayetteville.

FAYETTEVILLE – Two studies by researchers at the University of Arkansas for Medical Sciences (UAMS) have shed some light on Arkansans’ preferred locations for COVID-19 testing and the reasons why some people may decide not to get a test in the first place. “Due to the recent surge in COVID-19 cases and hospitalizations in Arkansas,…


July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…


July 20, 2021

UAMS Releases Findings from Statewide COVID-19 Antibody Study

David Robinson

A team at UAMS tested blood samples from July to December 2020 and found that by the end of the year, 7.4% of Arkansans had SARS-CoV-2 antibodies.

LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).


July 14, 2021

NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles

Linda Satter

Hari Eswaran, Ph.D. ,shows off SARA, which he helped develop.

The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.


July 9, 2021

UAMS Medical Student Published in JAMA Network Open

Linda Haymes

Austin Morgan, a third-year student in the College of Medicine, was recently published in JAMA Network Open, an international, peer-reviewed, open access, general medical journal that focuses on original research articles and commentary on a variety of medical and health topics.

The Journal of the American Medical Association (JAMA) recently published University of Arkansas for Medical Sciences (UAMS) medical student Austin Morgan’s results from his study on diversity among cancer centers’ leadership.


July 7, 2021

Researcher Finds Challenges in Study Involving Methamphetamine

Linda Haymes

Michael Wilson, M.D., an assistant professor of Emergency Medicine, is studying how methamphetamine affects the human body, particularly how the body responds to stress.

If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.

“Use meth?”



Next page